Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.62 | N/A |
| PEG Ratio (TTM) | 9.03 | N/A |
| P/S Ratio (TTM) | 1.50 | N/A |
| P/B Ratio (TTM) | 1.14 | N/A |
| P/FCF Ratio (TTM) | -61.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.09 | N/A |
| Price to 5YR AVG FCF Ratio | -21.60 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.53% | N/A |
| ROE (TTM) | 7.83% | N/A |
| Net Profit Margin (TTM) | 10.25% | N/A |
| ROIC 5YR AVG | 4.66% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 90.97% | 5.95% | 4.79% |
| Revenue | 4.50% | 1.14% | 4.94% |
| Net Income | 92.39% | 7.97% | 7.91% |
| Cash Flow | 41.02% | -8.69% | 36.07% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.75 | N/A |
| Quick Ratio (TTM) | 0.48 | N/A |
| D/E Ratio (TTM) | 1.03 | N/A |
| Interest Coverage (TTM) | 2.11 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.84 | N/A |
| LTL to 5YR AVG FCF | -19.94 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.08% | N/A |